Skip to content
VuFind
Advanced
  • Opioid agonist pharmacotherapy...
  • Cite this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.
QR Code

Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention.

Bibliographic Details
Main Authors: Burns, L., Randall, D., Hall, W., Law, M, Butler, Tony, Bell, J., Degenhardt, L.
Format: Journal Article
Published: Wiley-Blackwell Publishing Ltd. 2009
Online Access:http://hdl.handle.net/20.500.11937/22443
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://hdl.handle.net/20.500.11937/22443

Similar Items

  • A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
    by: Burns, L., et al.
    Published: (2015)
  • Mortality among clients of a state-wide opiod pharmacotherapy program over 20 years: Risk factors and lives saved
    by: Butler, Tony, et al.
    Published: (2009)
  • Imprisonment of opioid-dependent people in New South Wales, Australia, 2000-2012: A retrospective linkage study
    by: Degenhardt, L., et al.
    Published: (2014)
  • Increasing cancer mortality among opioid-dependent persons in Australia: A new public health challenge for a disadvantaged population
    by: Randall, D., et al.
    Published: (2011)
  • Studies on the biased signalling of some novel delta opioid receptor agonists
    by: Asghar, Muhammad Junaid
    Published: (2017)

Search Options

  • Advanced Search

Find More

  • Browse the Catalog

Need Help?

  • Search Tips